Relmada Therapeutics
Show contact
Links
Previous companies
Sergio Traversa
CEO
Helen Parker
Senior Medical Science Liaison
Judy Caron
Vice President of Drug Development
Charles S. Ence
Chief Accounting and Compliance Officer
Paolo Manfredi
Chief Scientific Officer
+ 5 more
April, 2022 - present
View in org chart
